Prescription drug costs continue to rise in Colorado, and represent one of the biggest health care cost drivers. To address rising costs, SB21-175 was passed establishing a Prescription Drug Affordability Review Board (PDAB). Join our February webinar to learn more about trends in prescription drug costs in Colorado, including drug rebates, and the three primary areas of focus for the PDAB in the upcoming years:

1. Increasing transparency around prescription drug reporting
2. Affordability board review and recommendations
3. Upper payment limit development

Presenters:
• Kristin Paulson, MPH, JD, CIVHC Chief Operating Officer
• Lila Cummings, MHS, PMP, DOI Prescription Drug Affordability Director
• Callie Shelton, MSW, DOI Prescription Drug Affordability Board Policy Analyst